Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1

Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation

WUN 2026 National Summit Schedule Released

Registration NOW OPEN – 2026 Wake Up Narcolepsy Family Weekend

Surviving the Holidays with Narcolepsy: Boundaries, Self-Preservation and Finding Joy

2025 Wake Up Narcolepsy Special Research Update

Wake Up Narcolepsy Featured in 2025 “My Cause My Cleats” NFL Campaign by Nazir Stackhouse

Register now for WUN’s 2026 National Summit

Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation

2025 WUN Town Halls Wrap Up